Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the level of funding available to the NHS to tackle waiting lists for blood cancer treatment.

In 2021, we announced an additional £5.9 billion to support elective recovery, diagnostics and technology in the next three years. This includes £2.3 billion to increase the volume of diagnostic activity and launch community diagnostic centres to increase capacity for clinical tests, such as phlebotomy for the diagnosis of suspected blood cancers.

We have also committed an additional £15.7 billion from April 2022 to March 2025 for managing the ongoing impact of COVID-19, while reducing waiting times for elective care, including cancer treatments.